Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Diphenylpyraline hydrochloride
Cat. No.:
OB0225LY-0122
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Diphenylpyraline hydrochloride is a first-generation antihistamine with sedative effects.
Synonym:
4-Diphenylmethoxy-1-methylpiperidine hydrochloride; 132-18-3; Diphenylpyrilene; 4-(Diphenylmethoxy)-1-methylpiperidine; 4-(Benzhydryloxy)-1-methylpiperidine
CAS No.:
132-18-3
Compound CID:
3103
Formula:
C19H23NO·HCl
Formula Weight:
317.85
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Diphenylpyraline hydrochloride is commonly used to study allergies and anxiety disorders.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
Neuronal signaling; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
e5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 173.04 mM
